AGs Say it’s High Time for the Federal Government to Reschedule Cannabis

  • A coalition of 12 AGs wrote a letter to the Drug Enforcement Administration (DEA) in support of federal efforts to evaluate and reschedule cannabis from Schedule I to Schedule III under the federal Controlled Substances Act.
  • A Schedule I classification is reserved for substances with no medical value and those that are considered highly addictive, while Schedule III controlled substances are recognized to have a legitimate medical use and lower potential for abuse.
  • The letter urges that rescheduling cannabis would allow legal cannabis businesses to take certain federal tax exemptions, allow for more testing and research on the physical and mental effects of the substance, and remove barriers to regulation in states that have legalized cannabis use.